Boston Partners Long/Short Research Fund Investor Class BPRRX

Morningstar Medalist Rating
  • NAV / 1-Day Return$14.47  /  −0.34%
  • Fund Size$623.9M
  • Adjusted Expense Ratio1.660%
  • Net Expense Ratio2.170%
  • Fee Level: DistributionAbove Average
  • Share Class TypeNo Load
  • Morningstar CategoryLong-Short Equity
  • Equity Style Box (Funds)Mid Value
  • Minimum Initial Investment$2,500
  • Investment StatusOpen
  • TTM Yield0.94%
  • Turnover Ratio65%

Morningstar’s Analysis BPRRX

Will BPRRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Boston Partners Long/Short Rsrch Inv holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BPRRX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings10.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Asset Offset

18.76110M
—

Cash And Cash Equivalents

18.55109M
Cash and Equivalents

Cash Offset

13.5680M
—

Flex Ltd

1.9011M
Technology

Seagate Technology Holdings PLC

1.479M
Technology

Frontdoor Inc

1.408M
Consumer Cyclical

JPMorgan Chase & Co

1.277M
Financial Services

AbbVie Inc

1.096M
Healthcare

Wells Fargo & Co

1.096M
Financial Services

UnitedHealth Group Inc

1.036M
Healthcare

Sponsor Center